HCFA's Hands-Off Policy For Ocular Laser Therapy Leaves Control At Bedside
This article was originally published in The Gray Sheet
Executive Summary
HCFA's Nov. 8 decision on photodynamic laser treatments for age-related macular degeneration (AMD) demonstrates a new willingness to defer to physician judgement in the selection of appropriate patients.